Zydus Lifesciences Ltd

Zydus Lifesci. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Zydus Lifesciences Ltd

₹ 949 -0.25%
26 Apr 2:26 p.m.
zyduscadila.com BSE: 532321 NSE : ZYDUSLIFE
About

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20.
Adhering to its brand promise of being dedicated to life in all its dimensions, Zydus continues to innovate with an unswerving focus to address the unmet healthcare needs. Simultaneously it rededicates itself to its mission of creating healthier, happier communities across the globe

Key Points

One of the top five pharmaceutical companies in India.[1]

Website BSE NSE
  • Market Cap ₹ 95,477 Cr.
  • Current Price ₹ 949
  • High / Low ₹ 1,032 / 483
  • Stock P/E 35.5
  • Book Value ₹ 144
  • Dividend Yield 0.63 %
  • ROCE 14.2 %
  • ROE 12.1 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 31.3%

Cons

  • Stock is trading at 6.61 times its book value
  • The company has delivered a poor sales growth of 8.49% over past five years.
  • Company has a low return on equity of 11.3% over last 3 years.
  • Debtor days have increased from 114 to 147 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
1,919 2,008 2,123 2,009 1,830 1,977 1,981 2,262 2,013 2,579 2,956 2,159 2,371
1,421 1,415 1,506 1,525 1,472 1,519 1,437 1,583 1,554 1,807 1,815 1,510 1,672
Operating Profit 498 594 618 484 359 458 544 679 459 772 1,141 649 699
OPM % 26% 30% 29% 24% 20% 23% 27% 30% 23% 30% 39% 30% 29%
-162 -16 30 -250 26 54 52 109 136 47 82 534 107
Interest 16 20 44 24 25 42 41 64 88 85 90 91 104
Depreciation 113 115 117 119 120 123 123 124 122 120 121 125 128
Profit before tax 207 442 486 91 240 346 432 600 385 615 1,012 968 574
Tax % 32% -5% 18% 85% 18% 29% 23% 25% 34% 20% 23% 17% 22%
140 465 400 14 197 247 332 451 256 491 781 805 450
EPS in Rs 1.37 4.54 3.91 0.14 1.92 2.41 3.24 4.46 2.53 4.85 7.71 7.95 4.45
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
3,151 3,527 4,042 5,284 7,032 3,231 5,810 6,037 6,347 7,780 7,837 8,732 10,066
2,483 2,820 3,232 3,750 4,454 2,909 4,164 4,400 4,916 5,468 5,916 6,277 6,804
Operating Profit 668 708 810 1,535 2,578 322 1,646 1,637 1,432 2,312 1,921 2,454 3,262
OPM % 21% 20% 20% 29% 37% 10% 28% 27% 23% 30% 25% 28% 32%
237 51 305 184 174 582 208 598 848 -102 -144 345 771
Interest 126 111 42 43 26 11 64 90 234 71 135 278 370
Depreciation 108 117 127 212 221 251 293 358 429 451 479 489 494
Profit before tax 670 531 946 1,465 2,504 642 1,497 1,787 1,617 1,688 1,164 2,032 3,170
Tax % 2% 6% 4% 13% 19% -3% 27% 17% 13% 13% 26% 25%
658 499 904 1,271 2,038 662 1,091 1,486 1,413 1,476 858 1,529 2,527
EPS in Rs 6.42 4.87 8.83 12.42 19.90 6.47 10.66 14.51 13.80 14.42 8.38 15.11 24.96
Dividend Payout % 23% 31% 20% 19% 16% 50% 33% 24% 25% 24% 30% 40%
Compounded Sales Growth
10 Years: 9%
5 Years: 8%
3 Years: 11%
TTM: 22%
Compounded Profit Growth
10 Years: 12%
5 Years: 9%
3 Years: 3%
TTM: 109%
Stock Price CAGR
10 Years: 17%
5 Years: 24%
3 Years: 19%
1 Year: 85%
Return on Equity
10 Years: 16%
5 Years: 13%
3 Years: 11%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 102 102 102 102 102 102 102 102 102 102 102 101 101
Reserves 2,455 2,809 3,528 4,423 6,174 6,516 7,643 8,467 11,158 12,642 13,138 13,538 14,501
1,284 1,786 1,586 1,450 1,223 2,940 2,872 3,583 3,695 3,920 2,665 4,825 4,766
912 855 1,027 1,362 1,424 1,489 1,546 1,519 1,597 1,799 1,835 2,099 1,916
Total Liabilities 4,754 5,552 6,243 7,337 8,923 11,047 12,164 13,671 16,552 18,464 17,740 20,564 21,284
1,218 1,497 1,564 1,768 2,155 2,352 2,680 3,932 4,109 4,112 4,336 4,184 4,224
CWIP 312 464 531 367 297 678 659 675 553 570 384 739 777
Investments 1,212 1,280 1,558 2,209 2,318 3,924 3,618 4,195 6,404 6,471 5,118 4,879 5,831
2,012 2,311 2,591 2,993 4,154 4,093 5,206 4,868 5,486 7,310 7,902 10,761 10,452
Total Assets 4,754 5,552 6,243 7,337 8,923 11,047 12,164 13,671 16,552 18,464 17,740 20,564 21,284

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
372 445 878 1,084 1,954 867 288 581 1,181 2,227 1,272 1,078
-817 -709 -408 -577 -1,016 -2,480 28 -713 55 -2,714 586 -1,960
522 250 -446 -387 -923 1,366 -149 65 -967 255 -1,710 827
Net Cash Flow 76 -14 25 120 14 -247 167 -67 268 -231 149 -54

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 71 71 65 73 89 105 79 128 141 89 106 147
Inventory Days 176 169 171 178 127 338 284 288 261 276 245 205
Days Payable 100 104 119 148 174 361 173 137 161 175 135 120
Cash Conversion Cycle 148 136 117 102 42 82 190 279 241 191 216 232
Working Capital Days 50 72 61 53 70 74 118 161 138 205 225 208
ROCE % 24% 15% 20% 27% 38% 8% 15% 16% 14% 12% 10% 14%

Shareholding Pattern

Numbers in percentages

11 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
74.88% 74.88% 74.88% 74.88% 74.88% 74.98% 74.98% 74.98% 74.98% 74.98% 74.98% 74.98%
4.65% 4.11% 3.79% 2.53% 2.86% 2.61% 2.52% 3.42% 4.04% 4.85% 4.99% 5.72%
10.50% 11.25% 11.80% 12.83% 11.94% 12.86% 13.61% 13.51% 13.44% 13.01% 12.96% 12.55%
0.07% 0.07% 0.07% 0.08% 0.08% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07%
9.90% 9.69% 9.46% 9.69% 10.24% 9.47% 8.81% 8.01% 7.47% 7.07% 6.99% 6.66%
No. of Shareholders 3,31,1553,51,5953,70,9314,08,0174,55,6244,08,2313,70,3963,38,5703,11,7642,97,9533,06,4952,94,324

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls